Abstract
Oral cancer refers to malignant neoplasms arising in the mucosa of the lip, tongue and mouth (International Classification of Diseases 10th Edition (ICD-10) codes C00-06) which are lined by stratified squamous epithelium. More than 90 % of the cancers occurring in the oral cavity are squamous cell carcinomas of varying differentiation, predominantly caused by chronic exposure to tobacco use in any form, alcohol drinking or both and are rarely due to chronic traumatic irritation. However, there is considerable misclassification and overlapping of cancer sites when the generic term “oral cancer” is used such as malignant neoplasms originating in adjacent anatomical sites such as the oropharynx and hypopharynx, even larynx and oesophagus, have been included as “oral cancer” by many authors and reports in the scientific literature, which makes interpretation and comparison of oral cancer burden and outcomes somewhat challenging. Our discussion in this chapter refers to cancers occurring in ICD-10 sites C00-C06 as oral cancer. According to the most recent global estimates, oral cancer (C00-06) is the thirteenth most common cancer in the world, accounting for an estimated 300,000 new cases and 145,000 deaths in the world around 2012, of which 200,000 cases and 112,000 deaths occurred in less developed countries [1].
Similar content being viewed by others
References
Ferlay JF, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: IARC; 2013.
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, et al. Cancer Incidence in Five Continents, Vol. X (electronic version). Lyon: IARC; 2013.
Syrjanen S, Lodi G, von B I, Aliko A, Arduino P, Campisi G, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17 Suppl 1:58–72.
Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985–2010. Oral Oncol. 2011;47(11):1048–54.
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ. Cancer statistics review, 1975–2005. Bethesda: National Cancer Institute; 2008. Based on November 2007 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2005.
Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11:165–73.
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45:931–91.
Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean and Central America, IARC scientific publications, vol. 162. Lyon: International Agency for Research on Cancer; 2011.
Sankaranarayanan R, Swaminathan R, Lucas E. Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). 2011. Available at http://survcan.iarc.fr/.
Warnakulasuriya S, Johnson NW, van dW I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317–23.
Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1–10.
Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol. 2011;16:5–14.
Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med. 2007;36:25–9.
Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity: a systematic review. Oral Oncol. 2009;45:647–53.
Rahman MA, Amin AR, Shin DM. Chemopreventive potential of natural compounds in head and neck cancer. Nutr Cancer. 2010;62:973–87.
Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia – a systematic review and meta-analysis. Head Neck. 2009;31:1600–9.
Angadi PV, Rao S. Management of oral submucous fibrosis: an overview. Oral Maxillofac Surg. 2010;14:133–42.
Deppe H, Mucke T, Hohlweg-Majert B, Hauck W, Wagenpfeil S, Holzle F. Different CO(2) laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up. Lasers Med Sci. 2011;27(1):59–63.
Pandey M, Thomas G, Somanathan T, Sankaranarayanan R, Abraham EK, Jacob BJ, et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol. 2001;37:103–9.
Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I. Histological typing of cancer and precancer of the oral mucosa. International Classification of Tumours. Berlin: Springer; 1997.
Warnakulasuriya KA, Ekanayake AN, Sivayoham S, Stjernsward J, Pindborg JJ, Sobin LH, et al. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ. 1984;62:243–50.
Warnakulasuriya KA, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev. 1991;15:331–4.
Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev. 1986;9:219–25.
Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer. 1997;76:390–4.
Mashberg A, Barsa P. Screening for oral and oropharyngeal squamous carcinomas. CA Cancer J Clin. 1984;34:262–8.
Frenandez GL, Sankaranarayanan R, Lence Anta JJ, Rodriguez SA, Maxwell PD. An evaluation of the oral cancer control program in Cuba. Epidemiology. 1995;6:428–31.
Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol. 2004;40:264–73.
Sankaranarayanan R, Fernandez GL, Lence AJ, Pisani P, Rodriguez SA. Visual inspection in oral cancer screening in Cuba: a case–control study. Oral Oncol. 2002;38:131–6.
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365:1927–33.
Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ. 2009;87:200–6.
Mathew B, Sankaranarayanan R, Wesley R, Nair MK. Evaluation of mouth self-examination in the control of oral cancer. Br J Cancer. 1995;71:397–9.
Scott SE, Rizvi K, Grunfeld EA, McGurk M. Pilot study to estimate the accuracy of mouth self-examination in an at-risk group. Head Neck. 2010;32:1393–401.
Elango KJ, Anandkrishnan N, Suresh A, Iyer SK, Ramaiyer SK, Kuriakose MA. Mouth self-examination to improve oral cancer awareness and early detection in a high-risk population. Oral Oncol. 2011;47:620–4.
Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc. 2008;139:896–905.
Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009;1:5.
Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22.
Epstein JB, Sciubba J, Silverman Jr S, Sroussi HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck. 2007;29:948–58.
Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005;65:8017–21.
Oh ES, Laskin DM. Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg. 2007;65:424–6.
Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L, Swasdison S. The application of acetic acid in the detection of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:371–6.
De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005;41:117–31.
Trullenque-Eriksson A, Munoz-Corcuera M, Campo-Trapero J, Cano-Sanchez J, Bascones-Martinez A. Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir Bucal. 2009;14:E210–6.
Perez-Sayansm M, Somoza-Martin JM, Barros-Angueira F, Reboiras-Lopez MD, Gandara-Vila P, Gandara Rey JM, et al. Exfoliative cytology for diagnosing oral cancer. Biotech Histochem. 2010;85:177–87.
Cristallini EG, Padalino D, Bolis GB. Role of FNAB in the follow-up of cancer patients. Appl Pathol. 1989;7:219–24.
Balevi B. Assessing the usefulness of three adjunctive diagnostic devices for oral cancer screening: a probabilistic approach. Community Dent Oral Epidemiol. 2011;39:171–6.
Shpitzer T, Bahar G, Feinmesser R, Nagler RM. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol. 2007;133:613–7.
Nagler RM. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009;45:1006–10.
Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2006;3:CD004150.
Kujan O, Glenny AM, Sloan P. Screening for oral cancer. Lancet. 2005;366:1265–6.
National Cancer Institute. Oral cancer screening. U.S. National Institutes of Health. 2011. Available at http://www.cancer.gov/cancertopics/pdq/screening/oral/healthprofessional.
Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141:509–20.
Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, Mathew B. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol. 2013;49(4):314–21.
Ramadas K, Arrossi S, Thara S, Sankaranarayanan R. Keynote comment: importance of recognising scientific evidence. Lancet Oncol. 2006;7:962–3.
Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10:1–iv.
Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen. 2000;7:203–8.
Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000;36:340–6.
Nagao T, Warnakulasuriya S, Gelbier S, Yuasa H, Tsuboi S, Nakagaki H. Oral pre-cancer and the associated risk factors among industrial workers in Japan’s overseas enterprises in the UK. J Oral Pathol Med. 2003;32:257–64.
World Health Organization. Mortality database. 2011. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
Lin YS, Jen YM, Wang BB, Lee JC, Kang BH. Epidemiology of oral cavity cancer in Taiwan with emphasis on the role of betel nut chewing. ORL J Otorhinolaryngol Relat Spec. 2005;67:230–6.
Wang PE, Wang TT, Chiu YH, Yen AM, Chen TH. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? J Med Screen. 2006;13 Suppl 1:S54–8.
Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23:237–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sankaranarayanan, R., Somanathan, T., Thomas, G., Ramadas, K. (2017). Screening for Oral Cancer. In: Kuriakose, M.A. (eds) Contemporary Oral Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-14911-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-14911-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14910-3
Online ISBN: 978-3-319-14911-0
eBook Packages: MedicineMedicine (R0)